Cargando…

Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue

Multiple endocrine neoplasia type 2A (MEN2A) is a rare hereditary condition characterized by medullary thyroid cancer, pheochromocytoma, and primary hyperparathyroidism. The current standard of treatment of hyperparathyroidism involves surgical removal of visibly enlarged glands, and auto-transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Melisa, Koroscil, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359832/
https://www.ncbi.nlm.nih.gov/pubmed/37485129
http://dx.doi.org/10.7759/cureus.40715
_version_ 1785075970365980672
author Esposito, Melisa
Koroscil, Thomas
author_facet Esposito, Melisa
Koroscil, Thomas
author_sort Esposito, Melisa
collection PubMed
description Multiple endocrine neoplasia type 2A (MEN2A) is a rare hereditary condition characterized by medullary thyroid cancer, pheochromocytoma, and primary hyperparathyroidism. The current standard of treatment of hyperparathyroidism involves surgical removal of visibly enlarged glands, and auto-transplantation of remnant tissue is often considered to minimize the risk of iatrogenic post-surgical hypocalcemia if multiple glands are enlarged. Rarely, hyperparathyroidism may recur due to hyperplasia or adenoma formation in the auto-transplanted tissue. The following case portrays a 51-year-old male, with a history of MEN2A status post total parathyroidectomy with cryopreservation and subsequent auto-transplantation of remnant parathyroid tissue to the left arm 18 years prior, who presented to establish care due to the insidious development of asymptomatic hypercalcemia. Workup included a laboratory examination showing elevated intact parathyroid hormone (PTH) and left arm ultrasound revealing three areas of enlarged parathyroid tissue at the transplant site, raising suspicion for the development of recurrent primary hyperparathyroidism in auto-transplanted tissue. The patient ultimately underwent a re-do subtotal parathyroidectomy of auto-transplanted tissue with surgical pathology confirming hyperplastic parathyroid tissue. This case highlights the significance of indefinite vigilant surveillance in this patient population, as a recurrence of hyperparathyroidism may occur even after decades of remission.
format Online
Article
Text
id pubmed-10359832
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103598322023-07-22 Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue Esposito, Melisa Koroscil, Thomas Cureus Endocrinology/Diabetes/Metabolism Multiple endocrine neoplasia type 2A (MEN2A) is a rare hereditary condition characterized by medullary thyroid cancer, pheochromocytoma, and primary hyperparathyroidism. The current standard of treatment of hyperparathyroidism involves surgical removal of visibly enlarged glands, and auto-transplantation of remnant tissue is often considered to minimize the risk of iatrogenic post-surgical hypocalcemia if multiple glands are enlarged. Rarely, hyperparathyroidism may recur due to hyperplasia or adenoma formation in the auto-transplanted tissue. The following case portrays a 51-year-old male, with a history of MEN2A status post total parathyroidectomy with cryopreservation and subsequent auto-transplantation of remnant parathyroid tissue to the left arm 18 years prior, who presented to establish care due to the insidious development of asymptomatic hypercalcemia. Workup included a laboratory examination showing elevated intact parathyroid hormone (PTH) and left arm ultrasound revealing three areas of enlarged parathyroid tissue at the transplant site, raising suspicion for the development of recurrent primary hyperparathyroidism in auto-transplanted tissue. The patient ultimately underwent a re-do subtotal parathyroidectomy of auto-transplanted tissue with surgical pathology confirming hyperplastic parathyroid tissue. This case highlights the significance of indefinite vigilant surveillance in this patient population, as a recurrence of hyperparathyroidism may occur even after decades of remission. Cureus 2023-06-21 /pmc/articles/PMC10359832/ /pubmed/37485129 http://dx.doi.org/10.7759/cureus.40715 Text en Copyright © 2023, Esposito et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Esposito, Melisa
Koroscil, Thomas
Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
title Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
title_full Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
title_fullStr Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
title_full_unstemmed Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
title_short Remote Recurrent Primary Hyperparathyroidism in Auto-Transplanted Tissue
title_sort remote recurrent primary hyperparathyroidism in auto-transplanted tissue
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359832/
https://www.ncbi.nlm.nih.gov/pubmed/37485129
http://dx.doi.org/10.7759/cureus.40715
work_keys_str_mv AT espositomelisa remoterecurrentprimaryhyperparathyroidisminautotransplantedtissue
AT koroscilthomas remoterecurrentprimaryhyperparathyroidisminautotransplantedtissue